BDNF and obesity due to melanocortin 4 receptor deficiency: Our results strengthen the rationale to develop treatments addressing the BDNF pathways [38] to enrich the current multi-modal anti-obesity treatment options taking into account the partly redundant and complex mechanisms underlying the regulation of energy intake and expenditure [4].